MCP Server For Financial Data by EODHD Learn more

Try our APIs with free plan!

Polaryx Therapeutics, Inc. Common Stock Financial Data Overview

Price chart is built with Anychart

Polaryx Therapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery, development, and commercialization of disease-modifying therapies for rare and pediatric lysosomal storage disorders in the United States. Its pipeline includes PLX-100, a preclinical stage orally administrable combination therapy; PLX-200, a repurposed oral small molecule for the treatment of LSDs; PLX-300, a preclinical stage orally administrable combination therapy; and PLX-400, a preclinical stage novel gene therapy candidate. The company was founded in 2014 and is based in Paramus, New Jersey.

Prev. Close 2.0384
Open 1.993
High 2.0566
Low 1.9778
52 wk Range 1.85-48.91
Market Cap 95 160 K
Shares Outstanding 47 343 K
EPS -0.03

* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.


ETFs with Polaryx Therapeutics, Inc. Common Stock (top by weight)

Ticker
100-day Price Change
Weight
VTI.US Vanguard Total Stock Market Index Fund ETF Shares
12.34 (3.41%)
0.00
VXF.US Vanguard Extended Market Index Fund ETF Shares
5.56 (2.4%)
0.00

* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.


Why to choose EODHD?

Prices start at $19.99

24/7 Live support

Robust, powerful and reliable data

API Simplicity of a few lines of code


Try our APIs
with free plan!

Or get access to advanced financial data starting only $19.99

TRY NOW

Get Polaryx Therapeutics, Inc. Common Stock data using free add-ons & libraries


Get Polaryx Therapeutics, Inc. Common Stock Fundamental Data

Polaryx Therapeutics, Inc. Common Stock Fundamental data includes:

  • Net Revenue:
  • EBITDA:
  • Earnings Per Share: 0
  • Income Statements
  • Balance Sheets
  • Cash flows

Plans with Fundamental data

Starting from

$ 59.99 /mo.
COMPARE PLANS

End-of-day & Earnings data

Get Polaryx Therapeutics, Inc. Common Stock Earnings data

Corporate Events Calendar & News package for

$ 19.99 /mo.

What’s included:

  • Latest Release: 2026-08-13
  • EPS/Forecast: -0.05
GET THE PACKAGE

Get Polaryx Therapeutics, Inc. Common Stock End-of-day data

EOD Historical Data package for

$ 19.99 /mo.

What’s included:

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
GET THE PACKAGE

Polaryx Therapeutics, Inc. Common Stock News

Get Polaryx Therapeutics, Inc. Common Stock fresh news feed via Financial News API

Corporate Events Calendar & News package for

$19.99/mo.

Try our APIs
with free plan!

Or get access to advanced financial data starting only $19.99

TRY NOW
  • Flexibility: No long-term commitments, just a minimum of one month
  • Instant access: Get your API key and instructions within seconds of subscribing
Best Offer
All-In-One
$99.99/mo.

What’s included:

  • API Calls per Day: 100 000/day
  • API Requests per Min.: 1000/minute
  • Type of Usage: Personal use

Data access:

Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.

GET THE PACKAGE
Live chat support

Send the request

Leave your email and our team will contact you ASAP.